Stocks
Denali Therapeutics (DNLI) Operating Income US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -213.2 | 62.7 | -295.8 | -340.7 | -196.7 | -504.6 | |||
| Changes by years, y/y, % | +360% | -129% | -572% | +15% | -42% | +33.5% | |||
Denali Therapeutics. Operating Income, bln rub
Denali Therapeutics. Operating Income, changes, %
Denali Therapeutics. Operating Income, sum by quarters, bln rub
Denali Therapeutics (DNLI) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | -113.8 | -132.6 | -132.3 | -116.6 | -123.2 | -504.6 | ||
| Changes by years, y/y, % | +6% | +26% | +9% | -168% | +8% | |||
| Changes by quarters, q/q, % | -167% | +17% | 0% | -12% | +6% | |||
